Innovus Pharmaceuticals Inc (OTCMKTS:INNVD) was down 1.9% during trading on Tuesday . The stock traded as low as $1.50 and last traded at $1.52, approximately 541 shares changed hands during trading. A decline of 97% from the average daily volume of 17,924 shares. The stock had previously closed at $1.55.
Separately, ValuEngine raised Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st.
The stock’s 50-day moving average is $1.81. The company has a market capitalization of $3.59 million, a PE ratio of -0.37 and a beta of 2.89.
About Innovus Pharmaceuticals (OTCMKTS:INNVD)
Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.
Further Reading: Coverage Ratio
Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.